140 related articles for article (PubMed ID: 16806016)
1. [Biologic activity of bispecific single chain antibody against human gamma-seminoprotein and CD3 molecule].
Wang D; Wang H; Wu GJ; Wu WZ; Yang SL; Lin WH; Tan JM
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Jul; 22(4):500-3. PubMed ID: 16806016
[TBL] [Abstract][Full Text] [Related]
2. [Study on p53 tetramerization domain in improving functional affinity and biological activity of antibody].
Wang D; Wu GJ; Tan JM; Wang H
Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(7):479-82. PubMed ID: 15854555
[TBL] [Abstract][Full Text] [Related]
3. [Construction and expression of anti-CD3/anti-prostate-cancer bispecific single-chain antibody].
Wang D; Wu GJ; Wang H; Yang SL; Wu WZ; Xu TZ; Tan JM
Zhonghua Yi Xue Za Zhi; 2003 Aug; 83(15):1292-5. PubMed ID: 12930679
[TBL] [Abstract][Full Text] [Related]
4. Effects of different interchain linkers on biological activity of an anti-prostate cancer single-chain bispecific antibody.
Hao CH; Han QH; Shan ZJ; Hu JT; Zhang N; Zhang XP
Theor Biol Med Model; 2015 Aug; 12():14. PubMed ID: 26246000
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of biologic activity of two anti-PSA/anti-CD3 bispecific single-chain antibodies].
Wang D; Wu GJ; Wang H; Wu WZ; Yang SL; Tan JM
Zhonghua Nan Ke Xue; 2007 Jan; 13(1):8-12. PubMed ID: 17302025
[TBL] [Abstract][Full Text] [Related]
6. A bispecific diabody directed against prostate-specific membrane antigen and CD3 induces T-cell mediated lysis of prostate cancer cells.
Bühler P; Wolf P; Gierschner D; Schaber I; Katzenwadel A; Schultze-Seemann W; Wetterauer U; Tacke M; Swamy M; Schamel WW; Elsässer-Beile U
Cancer Immunol Immunother; 2008 Jan; 57(1):43-52. PubMed ID: 17579857
[TBL] [Abstract][Full Text] [Related]
7. Construction and in vivo evaluation of an anti-PSA x anti-CD3 bispecific antibody for the immunotherapy of prostate cancer.
Katzenwadel A; Schleer H; Gierschner D; Wetterauer U; Elsässer-Beile U
Anticancer Res; 2000; 20(3A):1551-5. PubMed ID: 10928069
[TBL] [Abstract][Full Text] [Related]
8. Effective targeting of prostate cancer by lymphocytes redirected by a PSMA × CD3 bispecific single-chain diabody.
Fortmüller K; Alt K; Gierschner D; Wolf P; Baum V; Freudenberg N; Wetterauer U; Elsässer-Beile U; Bühler P
Prostate; 2011 May; 71(6):588-96. PubMed ID: 20945402
[TBL] [Abstract][Full Text] [Related]
9. In vivo retargeting of T cell effector function by recombinant bispecific single chain Fv (anti-CD3 x anti-idiotype) induces long-term survival in the murine BCL1 lymphoma model.
De Jonge J; Heirman C; de Veerman M; Van Meirvenne S; Moser M; Leo O; Thielemans K
J Immunol; 1998 Aug; 161(3):1454-61. PubMed ID: 9686611
[TBL] [Abstract][Full Text] [Related]
10. [Expression, identification and bioactivity characterization of an anti-CD3/anti-CD20 bispecific single-chain antibody].
Yu R; Li SC; Wu BC; Liu H; Ye LL; Chen ZL
Sheng Wu Gong Cheng Xue Bao; 2005 Mar; 21(2):289-93. PubMed ID: 16013492
[TBL] [Abstract][Full Text] [Related]
11. [Construction and expression of diabody [CD3 x Pgp] without Etag].
Liu JN; Gao YD; Wang JH; Shao XF; Fan DM; Ji Q; Xiong DS; Yang CZ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Oct; 23(10):946-9. PubMed ID: 17908506
[TBL] [Abstract][Full Text] [Related]
12. Antitumor activities of PSMA×CD3 diabodies by redirected T-cell lysis of prostate cancer cells.
Baum V; Bühler P; Gierschner D; Herchenbach D; Fiala GJ; Schamel WW; Wolf P; Elsässer-Beile U
Immunotherapy; 2013 Jan; 5(1):27-38. PubMed ID: 23256796
[TBL] [Abstract][Full Text] [Related]
13. A tetravalent bispecific TandAb (CD19/CD3), AFM11, efficiently recruits T cells for the potent lysis of CD19(+) tumor cells.
Reusch U; Duell J; Ellwanger K; Herbrecht C; Knackmuss SH; Fucek I; Eser M; McAleese F; Molkenthin V; Gall FL; Topp M; Little M; Zhukovsky EA
MAbs; 2015; 7(3):584-604. PubMed ID: 25875246
[TBL] [Abstract][Full Text] [Related]
14. A recombinant bispecific single-chain fragment variable specific for HLA class II and Fc alpha RI (CD89) recruits polymorphonuclear neutrophils for efficient lysis of malignant B lymphoid cells.
Guettinger Y; Barbin K; Peipp M; Bruenke J; Dechant M; Horner H; Thierschmidt D; Valerius T; Repp R; Fey GH; Stockmeyer B
J Immunol; 2010 Feb; 184(3):1210-7. PubMed ID: 20042573
[TBL] [Abstract][Full Text] [Related]
15. [Expression and immunological activity of an anti-CD3×VEGFR2 bispecific single-chain antibody].
Dai LJ; Yan CW; Li SZ; Chen L; Li XY; Shan RH; Yu XW; Tang XB
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Aug; 27(8):883-6. PubMed ID: 21806887
[TBL] [Abstract][Full Text] [Related]
16. Retargeting of CTL by an efficiently refolded bispecific single-chain Fv dimer produced in bacteria.
Kurucz I; Titus JA; Jost CR; Jacobus CM; Segal DM
J Immunol; 1995 May; 154(9):4576-82. PubMed ID: 7536774
[TBL] [Abstract][Full Text] [Related]
17. [Construction, expression and functional characterization of single chain variable fragments (scFv) against human CD33 antigen].
Chen XJ; Wang Y; Qu H; Ge XS; Zuo YF; Liao XL
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Dec; 23(12):1147-9. PubMed ID: 18062889
[TBL] [Abstract][Full Text] [Related]
18. [Construction and expression of anti-human CD3 single chain Fv antibody/human p53 tetramerization domain fusion gene].
Wu GJ; Bai YJ; Wang D; Yu L; Wang Z; Wang H; Yao LB
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Sep; 20(5):560-2. PubMed ID: 15367347
[TBL] [Abstract][Full Text] [Related]
19. Bispecific tandem diabody for tumor therapy with improved antigen binding and pharmacokinetics.
Kipriyanov SM; Moldenhauer G; Schuhmacher J; Cochlovius B; Von der Lieth CW; Matys ER; Little M
J Mol Biol; 1999 Oct; 293(1):41-56. PubMed ID: 10512714
[TBL] [Abstract][Full Text] [Related]
20. A recombinant bispecific single-chain Fv antibody against HLA class II and FcgammaRIII (CD16) triggers effective lysis of lymphoma cells.
Bruenke J; Fischer B; Barbin K; Schreiter K; Wachter Y; Mahr K; Titgemeyer F; Niederweis M; Peipp M; Zunino SJ; Repp R; Valerius T; Fey GH
Br J Haematol; 2004 Apr; 125(2):167-79. PubMed ID: 15059139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
